Ourobio
Indianapolis, US · 1 known investors
Ourobio develops engineered microorganisms that convert industrial byproducts into biomaterials using synthetic biology. The company targets industries seeking sustainable alternatives to petroleum-derived chemicals and materials.
Founders & leadership
Investors · 1
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Environmental Protection Agency (EPA) | Phase I | 2023 | $100K |
| Environmental Protection Agency (EPA) | Phase I | 2021 | $100K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.